UC-MSCs

[Stem Cell Research & Therapy] Researchers compared the cytoprotection between peritoneal dialysis (PD) effluent-derived MSCs and umbilical cord-derived MSCs in the treatment of both peritoneal membrane and kidney injury in uremic rats with chronic PD.

[Stem Cell Research & Therapy] Scientists investigated the effects of storage solutions and heterogeneity on the behavior of MSCs in vitro and in vivo.

[Stem Cell Research & Therapy] Researchers investigated the therapeutic potential of human umbilical cord-derived MSCs in acute-on-chronic liver injury (ACLI) and ACLF rat models.

[Stem Cell Research & Therapy] The authors investigated the efficacy comparison and interaction between fasting-mimicking diet and umbilical cord-derived-MSC infusion, aiming to establish effective type 2 diabetes therapies and explore its mechanism.

[Stem Cell Research & Therapy] Scientists report a comprehensive comparison of human MSCs derived from umbilical cord Wharton’s jelly (UC-MSCs), dental pulp, and adipose tissue on the treatment of glucose and lipid metabolic disorders in type II diabetic mice.

[Stem Cell Research & Therapy] Umbilical cord (UC)-MSCs have few human leukocyte antigen-II and major histocompatibility complex class I molecules, and are easy to isolate and culture, UC-MSC sheets have been proposed as a candidate for clinical applications to ischemic heart disease.